These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6412273)

  • 61. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
    Pranzatelli MR; Snodgrass SR
    Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The development of response to continuous auditory stimulation in rats treated neonatally with 6-hydroxydopamine.
    Brackbill Y; Douthitt TC
    Dev Psychobiol; 1976 Jan; 9(1):5-15. PubMed ID: 1254106
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
    Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
    Sawynok J; Reid A; Nance D
    J Pharmacol Exp Ther; 1991 Jul; 258(1):370-80. PubMed ID: 1906540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
    Manaker S; Engber TM; Knight PB; Winokur A
    J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.
    Gerber R; Altar CA; Liebman JM
    Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of 6-hydroxydopamine and 5,7-dihydroxytryptamine on tissue uptake and cell nuclear retention of corticosterone in the rat hypothalamus.
    Weidenfeld J; Feldman S
    Brain Res; 1991 Dec; 566(1-2):140-5. PubMed ID: 1667607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
    Enters EK; Specht SM; Spear LP
    Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biochemical evidence for alteration of neostriatal dopaminergic function by 5,7-dihydroxytryptamine.
    Liston DR; Franz DN; Gibb JW
    J Neurochem; 1982 May; 38(5):1329-35. PubMed ID: 6121011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6-hydroxydopamine and 5,7-dihydroxytryptamine lesions.
    Porceddu ML; Imperato A; Melis MR; Di Chiara G
    Brain Res; 1983 Mar; 262(2):187-200. PubMed ID: 6404501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of TRH, ethanol, and TRH-ethanol combination on activity in rats with altered monoamine content.
    Breese GR; Coyle S; Frye GD; Mueller RA
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1013-8. PubMed ID: 3927322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 3H-5-hydroxytryptamine accumulation by rat brain synaptic vesicles in a membrane-impermeant medium, and selective reduction by 5,7-dihydroxytryptamine.
    Ruth JA; Cuizon JV; Park SH; Ullman EA; Wilson WR
    Life Sci; 1986 Mar; 38(13):1193-201. PubMed ID: 3959750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age.
    Finnegan KT; DeLanney LE; Irwin I; Ricaurte GA; Langston JW
    Brain Res; 1989 Sep; 496(1-2):251-6. PubMed ID: 2804634
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
    Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
    Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
    [No Abstract]   [Full Text] [Related]  

  • 79. Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria.
    Williams JH; Azmitia EC
    Brain Res; 1981 Feb; 207(1):95-107. PubMed ID: 7470907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noradrenergic-serotonergic interactions and nociception in the rat.
    Archer T; Jonsson G; Minor BG; Post C
    Eur J Pharmacol; 1986 Jan; 120(3):295-307. PubMed ID: 3081358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.